These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23972547)

  • 21. Pulmonary arterial hypertension and benfluorex: 5 case reports.
    Bondon-Guitton E; Prévôt G; Didier A; Montastruc JL
    Therapie; 2011; 66(2):135-8. PubMed ID: 21635861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The serotonin hypothesis of pulmonary hypertension revisited.
    Maclean MR; Dempsie Y
    Adv Exp Med Biol; 2010; 661():309-22. PubMed ID: 20204739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug-induced Pulmonary Hypertension - a Current Review].
    Günther S; Behr J; Knoop H
    Pneumologie; 2016 May; 70(5):320-7. PubMed ID: 27055781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appetite-suppressant drugs and primary pulmonary hypertension.
    Fishman AP
    N Engl J Med; 1997 Feb; 336(7):511; author reply 512-3. PubMed ID: 9019650
    [No Abstract]   [Full Text] [Related]  

  • 25. Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry.
    Bergot E; Sitbon O; Cottin V; Prévot G; Canuet M; Bourdin A; de Groote P; Rottat L; Gressin V; Jaïs X; Humbert M; Simonneau G
    Int J Cardiol; 2014 Apr; 172(3):561-7. PubMed ID: 24529947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.
    Abenhaim L; Moride Y; Brenot F; Rich S; Benichou J; Kurz X; Higenbottam T; Oakley C; Wouters E; Aubier M; Simonneau G; Bégaud B
    N Engl J Med; 1996 Aug; 335(9):609-16. PubMed ID: 8692238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary pulmonary arterial hypertension presenting as diffuse micronodules on CT.
    Horton MR; Tuder RM
    Crit Rev Comput Tomogr; 2004; 45(5-6):335-41. PubMed ID: 15747574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin transporter and serotonin receptors.
    Adnot S; Houssaini A; Abid S; Marcos E; Amsellem V
    Handb Exp Pharmacol; 2013; 218():365-80. PubMed ID: 24092348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dasatinib-induced pulmonary hypertension in acute lymphoblastic leukemia: case report.
    Taçoy G; Çengel A; Özkurt ZN; Türkoğlu S
    Turk Kardiyol Dern Ars; 2015 Jan; 43(1):78-81. PubMed ID: 25655855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.
    Shah NP; Wallis N; Farber HW; Mauro MJ; Wolf RA; Mattei D; Guha M; Rea D; Peacock A
    Am J Hematol; 2015 Nov; 90(11):1060-4. PubMed ID: 26284693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Iatrogenic pulmonary artery hypertension].
    Weitzenblum E; Kessler R; Chaouat A
    Rev Mal Respir; 1996; 13(2):133-9. PubMed ID: 8711232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of the Ongoing Story of Appetite Suppressants, Serotonin Pathway, and Pulmonary Vascular Disease.
    Bazan IS; Fares WH
    Am J Cardiol; 2016 May; 117(10):1691-1696. PubMed ID: 27018933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases.
    Souza R; Humbert M; Sztrymf B; Jaïs X; Yaïci A; Le Pavec J; Parent F; Hervé P; Soubrier F; Sitbon O; Simonneau G
    Eur Respir J; 2008 Feb; 31(2):343-8. PubMed ID: 17959632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis.
    Eddahibi S; Adnot S
    Respir Res; 2002; 3(1):9. PubMed ID: 11806844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary arterial hypertension induced by tyrosine kinase inhibitors.
    Weatherald J; Chaumais MC; Montani D
    Curr Opin Pulm Med; 2017 Sep; 23(5):392-397. PubMed ID: 28639957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anorectics and pulmonary hypertension].
    Bíbová J; Hampl V
    Cas Lek Cesk; 2000 Feb; 139(3):67-70. PubMed ID: 10838744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
    Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
    Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dasatinib-induced pulmonary arterial hypertension.
    Özgür Yurttaş N; Eşkazan AE
    Br J Clin Pharmacol; 2018 May; 84(5):835-845. PubMed ID: 29334406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reversible pulmonary arterial hypertension related to dasatinib in the treatment for chronic myelogenous leukemia: a case report and literature review].
    Liu B; Wang Y; Mi Y; Wang J
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):581-6. PubMed ID: 25052596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediators and modulators of pulmonary arterial hypertension.
    Said SI
    Am J Physiol Lung Cell Mol Physiol; 2006 Oct; 291(4):L547-58. PubMed ID: 16698850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.